Daiwa Securities Group
PASG icon

Daiwa Securities Group’s Passage Bio PASG Stock Holding History

Daiwa Securities Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9
Closed – – 1364
2022
Q3 		$0 Hold
9
– – ﹤0.01% 1374
2022
Q2 		$0 Hold
9
– – ﹤0.01% 1408
2022
Q1 		$1K Hold
9
– – ﹤0.01% 1325
2021
Q4 		$1K Hold
9
– – ﹤0.01% 1350
2021
Q3 		$2K Buy
9
+5
+125% +$1.19K ﹤0.01% 1245
2021
Q2 		$1K Hold
4
– – ﹤0.01% 1205
2021
Q1 		$2K Hold
4
– – ﹤0.01% 1153
2020
Q4 		$2K Buy
+4
New +$1.6K ﹤0.01% 1131

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Daiwa Securities Group's PASG Position: Q4 2022 in Review

Daiwa Securities Group sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 9 shares.

Daiwa Securities Group first reported a position in PASG in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q3 2021. 67 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Daiwa Securities Group reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 9 Passage Bio shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Passage Bio in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's Passage Bio position peaked at $2K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.